Ceftazidime-Avibactam plus aztreonam synergistic combination tested against carbapenem-resistant Enterobacterales characterized phenotypically and genotypically: a glimmer of hope

Sattler J, Brunke A, Hamprecht A. Systematic comparison of three commercially available combination disc tests and the zinc-supplemented carbapenem inactivation method (zCIM) for carbapenemase detection in Enterobacterales isolates. J Clin Microbiol. 2021;59(9): e0314020.

Article  PubMed  Google Scholar 

van Duin D, Doi Y. The global epidemiology of carbapenemase-producing Enterobacteriaceae. Virulence. 2017;8(4):460–9.

Article  PubMed  Google Scholar 

Rawson TM, Brzeska-Trafny I, Maxfield R, Almeida M, Gilchrist M, Gonzalo X, et al. A practical laboratory method to determine ceftazidime-avibactam-aztreonam synergy in patients with New Delhi metallo-beta-lactamase (NDM)-producing Enterobacterales infection. J Global Antimicrobial Resist. 2022;29:558–62.

Article  CAS  Google Scholar 

Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268–81.

Article  CAS  PubMed  Google Scholar 

Hu W, Li M, Lu W, Guo S, Li J. Evaluation of MASTDISCS combi Carba plus for the identification of metallo-β-lactamases, KPC and OXA-48 carbapenemase genes in Enterobacteriaceae clinical isolates. Lett Appl Microbiol. 2020;70(1):42–7.

Article  CAS  PubMed  Google Scholar 

Saito R, Koyano S, Dorin M, Higurashi Y, Misawa Y, Nagano N, et al. Evaluation of a simple phenotypic method for the detection of carbapenemase-producing Enterobacteriaceae. J Microbiol Meth. 2015;108:45–8.

Article  CAS  Google Scholar 

Ohsaki Y, Kubo R, Hobson J, Davies M, Osaka S, Hayashi W, et al. MASTDISCS combi Carba plus, a simple method for discriminating carbapenemase-producing Enterobacteriaceae, including OXA-48-type producers. Microbiol Immunol. 2018;62(1):60–5.

Article  CAS  PubMed  Google Scholar 

Zou C, Wei J, Shan B, Chen X, Wang D, Niu S. In vitro activity of ceftazidime-avibactam and aztreonam-avibactam against carbapenem-resistant Enterobacteriaceae isolates collected from three secondary hospitals in Southwest China between 2018 and 2019. Infect Drug Resist. 2020;13:3563–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Falcone M, Daikos GL, Tiseo G, Bassoulis D, Giordano C, Galfo V, et al. Efficacy of ceftazidime-avibactam plus aztreonam in patients with bloodstream infections caused by metallo-β-lactamase-producing Enterobacterales. Clinical Infect Dis. 2021;72(11):1871–8.

Article  CAS  Google Scholar 

Clinical and Laboratory Standards Institute [CLSI]. Performance standards for antimicrobial susceptibility testing, approved standard M100-S30. 31st ed. Wayne, PA.: CLSI; 2021.

Nordmann P, Naas T, Poirel L. Global spread of Carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis. 2011;17(10):1791–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Poirel L, Walsh TR, Cuvillier V, Nordmann P. Multiplex PCR for detection of acquired carbapenemase genes. Diagn Microbiol Infect Dis. 2011;70(1):119–23.

Article  CAS  PubMed  Google Scholar 

Monteiro J, Widen RH, Pignatari AC, Kubasek C, Silbert S. Rapid detection of carbapenemase genes by multiplex real-time PCR. J Antimicrob Chemother. 2012;67(4):906–9.

Article  CAS  PubMed  Google Scholar 

Grundmann H, Glasner C, Albiger B, Aanensen DM, Tomlinson CT, Andrasević AT, et al. Occurrence of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in the European survey of carbapenemase-producing Enterobacteriaceae (EuSCAPE): a prospective, multinational study. Lancet Infect Dis. 2017;17(2):153–63.

Article  CAS  PubMed  Google Scholar 

Kotb S, Lyman M, Ismail G, Abd El Fattah M, Girgis SA, Etman A, et al. Epidemiology of Carbapenem-resistant Enterobacteriaceae in Egyptian intensive care units using National Healthcare-associated Infections Surveillance Data, 2011–2017. Antimicrob Resist Infect Control. 2020;9(1):2.

Article  PubMed  PubMed Central  Google Scholar 

Sader HS, Carvalhaes CG, Arends SJR, Castanheira M, Mendes RE. Aztreonam/avibactam activity against clinical isolates of Enterobacterales collected in Europe, Asia and Latin America in 2019. J Antimicrob Chemother. 2020;76(3):659–66.

Article  Google Scholar 

Hegazy EE, Bahey MG, Abo Hagar AM, Elkholy AA, Mohamed EA. Carbapenem-Resistant gram-negative Bacilli causing ventilator associated Pneumonia: Study of MASTDISCS Combi Carba Plus for detection of Carbapenemase producing Enterobacterales. Infect Drug Resist. 2022;15:6331–42.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vamsi SK, Moorthy RS, Hemiliamma MN, Chandra Reddy RB, Chanderakant DJ, Sirikonda S. Phenotypic and genotypic detection of carbapenemase production among gram negative bacteria isolated from hospital acquired infections. Saudi Med J. 2022;43(3):236–43.

Article  PubMed  PubMed Central  Google Scholar 

Tian X, Zheng X, Sun Y, Fang R, Zhang S, Zhang X, et al. Molecular mechanisms and epidemiology of carbapenem-resistant Escherichia coli Isolated from Chinese patients during 2002–2017. Infect Drug Resist. 2020;13:501–12.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Haji SH, Aka STH, Ali FA. Prevalence and characterisation of carbapenemase encoding genes in multidrug-resistant Gram-negative bacilli. PLoS ONE. 2021;16(11): e0259005.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Al-Baz AA, Maarouf A, Marei A, Abdallah AL. Prevalence and antibiotic resistance profiles of carbapenem-resistant Klebsiella Pneumoniae isolated from tertiary care hospital Egypt. Egyptian J Hos Med. 2022;88(1):2883–90.

Article  Google Scholar 

He G, Huang J, Huang S, Sun J, Zhou Y, Tan H, et al. Risk factors affecting clinical outcome in patients with carbapenem-resistant K pneumoniae: a retrospective study. Med Sci Monitor. 2020;26:e925693.

Article  Google Scholar 

El-Badawy MF, El-Far SW, Althobaiti SS, Abou-Elazm FI, Shohayeb MM. The First Egyptian report showing the co-existence of bla (NDM-25), bla (OXA-23), bla (OXA-181), and bla (GES-1) among carbapenem-resistant K. pneumoniae clinical isolates genotyped by BOX-PCR. Infect Drug Resist. 2020;13:1237–50.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cui X, Zhang H, Du H. Carbapenemases in Enterobacteriaceae: detection and antimicrobial therapy. Front Microbiol. 2019;10:1823.

Article  PubMed  PubMed Central  Google Scholar 

Tawfick MM, Alshareef WA, Bendary HA, Elmahalawy H, Abdulall AK. The emergence of carbapenemase blaNDM genotype among carbapenem-resistant Enterobacteriaceae isolates from Egyptian cancer patients. Eur J Clin Microbiol Infect Dis. 2020;39(7):1251–9.

Article  CAS  PubMed  Google Scholar 

Han R, Shi Q, Wu S, Yin D, Peng M, Dong D, et al. Dissemination of carbapenemases (KPC, NDM, OXA-48, IMP, and VIM) among carbapenem-resistant Enterobacteriaceae isolated from adult and children patients in China. Front Cell Infect Microbiol. 2020;10:314.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Alhazmi W, Al-Jabri A, Al-Zahrani I. The molecular characterization of nosocomial carbapenem-resistant Klebsiella pneumoniae Co-Harboring blaNDM and blaOXA-48 in Jeddah. Microbiol Res. 2022;13(4):753–64.

Article  Google Scholar 

Makharita RR, El-Kholy I, Hetta HF, Abdelaziz MH, Hagagy FI, Ahmed AA, et al. Antibiogram and genetic characterization of carbapenem-resistant gram-negative pathogens incriminated in healthcare-associated infections. Infect Resist. 2020;13:3991–4002.

Article  CAS  Google Scholar 

Naim H, Rizvi M, Gupta R, Azam M, Taneja N, Shukla I, et al. Drug resistance and molecular epidemiology of carbapenem resistant gram-negative Bacilli isolates. J Global Infect Dis. 2018;10(3):133–9.

Article  CAS  Google Scholar 

Abdelaziz NA. Phenotype-genotype correlations among carbapenem-resistant Enterobacterales recovered from four Egyptian hospitals with the report of SPM carbapenemase. Antimicrob Resist Infect Control. 2022;11(1):13.

Article  PubMed  PubMed Central  Google Scholar 

Govindaswamy A, Bajpai V, Khurana S, Batra P, Mathur P, Malhotra R. Prevalence and characterization of carbapenemase-producing Escherichia coli from a tertiary care hospital in India. J Global Infect Dis. 2019;11(3):123–4.

Article  Google Scholar 

Ortega A, Sáez D, Bautista V, Fernández-Romero S, Lara N, Aracil B, et al. Carbapenemase-producing Escherichia coli is becoming more prevalent in Spain mainly because of the polyclonal dissemination of OXA-48. J Antimicrob Chemother. 2016;71(8):2131–8.

Article  PubMed  Google Scholar 

Jomehzadeh N, Jahangirimehr F, Chegeni SA. Virulence-associated genes analysis of carbapenemase-producing Escherichia coli isolates. PLoS ONE. 2022;17(5): e0266787.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ragheb SM, Tawfick MM, El-Kholy AA, Abdulall AK. Phenotypic and genotypic features of Klebsiella pneumoniae harboring carbapenemases in Egypt: OXA-48-like carbapenemases as an investigated model. Antibiotics. 2020. https://doi.org/10.3390/antibiotics9120852.

Article  PubMed  PubMed Central  Google Scholar 

Çalık Ş, Kansak N, Aksaray S. Phenotypic detection of carbapenemase production in carbapenem-resistant isolates with the rapid carbapenemase detection method (rCDM). J Microbiol Methods. 2022;200: 106536.

Article  PubMed  Google Scholar 

Gatya Al-Mayahie SM, Al-Guranie DRdT, Hussein AA, Bachai ZA. Prevalence of common carbapenemase genes and multidrug resistance among uropathogenic Escherichia coli phylogroup B2 isolates from outpatients in Wasit Province/Iraq. PLOS ONE. 2022;17(1):e0262984.

Article  CAS  PubMed  PubMed Central 

留言 (0)

沒有登入
gif